Vahram Haroutunian, PhD
- PROFESSOR | Psychiatry
- PROFESSOR | Neuroscience
Research Topics:
Aging, Alzheimer's Disease, Gene Expressions, Myelination, Neurotransmitters, Post-Transcriptional Processing, Prefrontal Cortex, Psychiatry, RNA, SchizophreniaDr. Haroutunian joined the faculty at The Mount Sinai School of Medicine in the summer of 1982 and is Professor of Psychiatry and Neuroscience. Dr. Haroutunian came to Mount Sinai after completing a postdoctoral training program at Princeton concentrating on research in development in aging. His research interests since joining the Mount Sinai faculty have centered on the neurobiology of Alzheimer’s disease, successful aging and schizophrenia. He directs the Mount Sinai NIH Neurobiobank and the Alzheimer’s Disease Research Center Neuropathology Core. Dr. Haroutunian is Principal Investigator on over 10 different NIH grants and contracts. He is also the Associate Director for Research for the Veterans Administration Mental Illness Research and Education Clinical Center. Dr. Haroutunian’s research interests include gene and protein expression at the single cell level in health and disease; development of novel approaches for the study of the human brain, including laser capture microdissection, digital neuropathology, application of artificial intelligence to reveal pathological and neuroanatomical features not immediately appreciated by the human eye. Dr. Haroutunian’s lab collaborates extensively the laboratories of Dr. Panagiotis Roussos, Dr. Bin Zhang, and Dr. Pavel Katsel.
Multi-Disciplinary Training Areas
Development Regeneration and Stem Cells [DRS], Neuroscience [NEU]Education
PhD, Kent State University
Princeton University
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Haroutunian during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Cold Spring Harbor Laboratory (CSHL); Synaptec
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.